The objectives of our study were to compare the prevalence of major depressive symptoms between subgroups of pregnant women: working women, women who had stopped working, housewives and students; and to identify risk factors for major depressive symptoms during pregnancy. The CES-D scale (Center for Epidemiological Studies Depression scale) was used to measure major depressive symptoms (CES-D score ≥23) in 5337 pregnant women interviewed at 24–26 weeks of pregnancy. Multivariate logistic regression models were developed to identify risk factors associated with major depressive symptoms. Prevalence of major depressive symptoms was 11.9% (11.0–12.8%) for all pregnant women. Working women had the lowest proportion of major depressive symptoms [7.6% (6.6–8.7%); n = 2514] compared to housewives [19.1% (16.5–21.8%); n = 893], women who had stopped working [14.4% (12.7–16.1%); n = 1665], and students [14.3% (10.3–19.1%); n = 265]. After adjusting for major risk factors, the association between pregnant women’s employment status and major depressive symptoms remained significant for women who had stopped working (OR: 1.61; 95% CI 1.26 to 2.04) and for housewives (OR: 1.46; 95% CI 1.10 to 1.94), but not for students (OR: 1.37; 95% CI 0.87 to 2.16). In multivariate analyses, low education, low social support outside of work, having experienced acute stressful events, lack of money for basic needs, experiencing marital strain, having a chronic health problem, country of birth, and smoking were significantly associated with major depressive symptoms. Health professionals should consider the employment status of pregnant women when they evaluate risk profiles. Prevention, detection and intervention measures are needed to reduce the prevalence of prenatal depression.
Background: To plan and implement services to persons who inject drugs (PWID), knowing their number is essential. For the island of Montréal, Canada, the only estimate, of 11 700 PWID, was obtained in 1996 through a capture-recapture method. Thirteen years later, this study was undertaken to produce a new estimate.Methods: PWID were defined as individuals aged 14-65 years, having injected recently and living on the island of Montréal. The study period was 07/01/2009 to 06/30/2010. An estimate was produced using a six-source capture-recapture log-linear regression method. The data sources were two epidemiological studies and four drug dependence treatment centres. Model selection was conducted in two steps, the first focusing on interactions between sources and the second, on age group and gender as covariates and as modulators of interactions.Results: A total of 1 480 PWID were identified in the six capture sources. They corresponded to 1 132 different individuals. Based on the best-fitting model, which included age group and sex as covariates and six two-source interactions (some modulated by age), the estimated population was 3 910 PWID (95% confidence intervals (CI): 3 180-4 900) which represents a prevalence of 2.8 (95% CI: 2.3-3.5) PWID per 1000 persons aged 14-65 years. Conclusions:The 2009-2010 estimate represents a two-thirds reduction compared to the one for 1996. The multisource capture-recapture method is useful to produce estimates of the size of the PWID population. It is of particular interest when conducted at regular intervals thus allowing for close monitoring of the injection phenomenon. 3-6 key words or phrases:Injection drug use Capture-recapture Log-linear model Canada Word count: 4134 4
An effective coordination between community-based perinatal services and hospital-linked home phototherapy in the form of an integrated network appears to be an essential condition for improved monitoring of newborns' health since it fosters a follow-up that is focused not only on jaundice but also on mothers' and newborns' needs while reducing the costs generated by newborn readmissions.
Objective: Evaluate the association between psychosocial work demands and major depressive symptoms among working pregnant women.Methods: Karasek's abbreviated scale was used to measure psychosocial work demands (Job strain and "Iso-strain") and CES-D scale (Center for Epidemiological Studies Depression Scale) was used to measure major depressive symptoms (CES-D score ≥23) among 3765 working pregnant women interviewed at 24-26 weeks of pregnancy. Three series of logistic regression analyses were conducted to explore associations with: 1) the "demand-control" or "job strain" model; 2) the "demand-control-support" or "Iso-strain" models; 3) the three Karasek stress dimensions (job demand, job control and social support) forced individually into the same model. We examined the "buffer" hypothesis of "demand-control-support" model.Results: Prevalence of major depressive symptoms was 9.8% (95% CI: 8.7-10.8%). In all, 24.4% of pregnant working women were exposed to "high-strain" jobs (high demand and low control) and 17% to "Iso-strain" ("high-strain" job with low support at work). In bivariate and multivariate analyses, pregnant women who had "high-strain" or "Iso-strain" jobs were more likely to have major depressive symptoms. Psychosocial work demands were associated with the mental health of pregnant women, when other organizational and personal factors which they encountered outside the work settings were taken into account. The "buffer" hypothesis was refuted. Conclusion:Our study confirms accumulated findings related to Karasek and Theorell's "demandcontrol" and "demand-control-support" theoretical models. The impact of the "demand-control-support" model and the critical role of social support at work have been demonstrated among working pregnant women.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.